As of 17 Sept 2026, Divis Laboratories Ltd share price is ₹9,279.50. The stock opened at ₹9,279.50 and had closed at ₹9,199.70 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹5,637.50 and a high of ₹10,000.00. In terms of performance, Divis Laboratories Ltd share price has increased by 49.72% over the past six months and has increased by 50.76% over the last year.
DIVISLAB Stock Price Chart
Divis Laboratories Ltd Overview
About DIVISLAB
Divis Laboratories is engaged in the manufacture of Active Pharmaceutical ingredients Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generics, the Company, through its custom synthesis, supports innovator pharma
Divis Laboratories Ltd Historical Performance
DIVISLAB Futures & Options
Divis Laboratories Ltd Fundamentals
Divis Laboratories Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 10,894.00 | 9,550.00 | 8,002.00 | 7,974.00 | 8,991.08 |
| EBITDA | 3,920.00 | 3,331.00 | 2,511.00 | 2,697.00 | 3,987.72 |
| Net Profit | 2,607.00 | 2,209.00 | 1,576.00 | 1,808.00 | 2,948.54 |
| EPS | 98.19 | 83.20 | 59.37 | 68.11 | 111.07 |
Divis Laboratories Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 9,015.67 |
| Resistance 1 (R1) | 9,291.72 |
| Pivot Point | 9,107.68 |
Divis Laboratories Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 24-Jul-2026 | 23-May-2026 | 24-Jul-2026 | Final | ₹30.00 |
| 25-Jul-2025 | 17-May-2025 | 25-Jul-2025 | Final | ₹30.00 |
| 02-Aug-2024 | 25-May-2024 | 02-Aug-2024 | Final | ₹30.00 |
| 11-Aug-2023 | 20-May-2023 | 11-Aug-2023 | Final | ₹30.00 |
| 11-Aug-2022 | 23-May-2022 | 12-Aug-2022 | Final | ₹30.00 |
DIVISLAB Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Ramesh B V Nimmagadda | Chairman |
| Murali K Divi | Managing Director |
| N V Ramana | Executive Directorector |
Divis Laboratories Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,858.60+0.28% | ₹4,19,727.66 | 38.32 | 13.74% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,812.50+0.00% | ₹1,46,951.32 | 64.68 | 25.49% |
| Dr Reddys Laboratories LtdDRREDDY | ₹1,155.60+1.37% | ₹1,07,764.93 | 19.51 | 11.07% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Divis Laboratories Ltd today is ₹9,279.50 on NSE and ₹9,279.50 on BSE.
- The 52-week high of Divis Laboratories Ltd is ₹10,000.00, while the 52-week low is ₹5,637.50.
- The current market capitalisation of Divis Laboratories Ltd is approximately ₹2,44,223 crore.
- The P/E (Price-to-Earnings) ratio of Divis Laboratories Ltd is 67.46. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Divis Laboratories Ltd is 10.85. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Divis Laboratories Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for DIVISLAB on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Divis Laboratories Ltd has delivered a return of approximately 141.16%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Divis Laboratories Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 51.88% promoters, 6.33% FIIs, 19.38% DIIs, and 6.41% public shareholders.

